AM-087
AM-087 (Cannabinoid Agonist)[edit | edit source]
AM-087, part of the AM cannabinoid series, is an analgesic drug that functions as a cannabinoid agonist. As a derivative of Δ8-THC, this compound stands out due to its significant potency and specific structural modifications that contribute to its efficacy.
Chemistry and Structure[edit | edit source]
AM-087 is chemically derived from Δ8-THC, which is a naturally occurring cannabinoid found in cannabis. The distinguishing structural feature of AM-087 is the substitution on the 3-position side chain. This substitution incorporates a bulky bromine substituent, which is believed to contribute to its heightened potency.
Mechanism of Action[edit | edit source]
The primary mechanism through which AM-087 exerts its analgesic effects is by acting as an agonist for the CB1 receptor. The CB1 receptor is one of the major cannabinoid receptors in the body and plays a crucial role in the modulation of pain sensation.
Potency[edit | edit source]
Compared to THC itself, AM-087 showcases significant potency. It has a Ki of 0.43 nM, signifying its high affinity for the CB1 receptor. This makes AM-087 approximately 100 times more potent than THC, emphasizing the importance and potential impact of structural modifications in drug design.
Therapeutic Potential and Research[edit | edit source]
Given its potency and specificity, AM-087 holds promise for therapeutic applications, particularly in pain management. Its ability to selectively target CB1 receptors may provide avenues for targeted therapies in conditions characterized by chronic pain.
Potential Side Effects[edit | edit source]
As with other cannabinoids and their analogs, potential side effects and long-term implications of AM-087 use must be thoroughly investigated. It's crucial to consider the drug's safety profile in comparison to its therapeutic benefits.
See Also[edit | edit source]
References[edit | edit source]
- "The AM cannabinoid series: A comprehensive review" - Journal of Medicinal Chemistry
- "The structural modifications and associated potency variations in Δ8-THC derivatives" - Cannabinoid Research Journal
 | This cannabinoid related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
